PATH
Menu

Filter browse results

Total results with these characteristics: 346

Subject: Emerging and epidemic diseases

Page 5 of 18
Directions in Global Health (Volume 10, Issue 1)

This issue of Directions in Global Health features work by OneWorld Health, PATH’s drug development program, to lead development of innovative methods to enhance the supply of artemisinin, a key ingredient in malaria treatments. It includes a commentary by Dr. Ponni Subbiah, who directs PATH’s drug development efforts. Other articles cover work to improve cervical cancer screening, protect infants from respiratory syncytial virus, increase access to family planning, and strengthen and expand use of human milk banking.

Publication date: May 2013

Region: Global

Part of series: Directions in Global Health

Investigating Live Attenuated Influenza Vaccine Efficacy in Senegal

This fact sheet describes a phase 3 clinical study that PATH and our partners are conducting in Senegal to evaluate the clinical efficacy of a seasonal, trivalent live attenuated influenza vaccine (LAIV). By providing evidence on how well this type of vaccine works among young children in Senegal, this study will help inform efforts in the scientific community to develop optimal LAIVs for the world’s most vulnerable children, as well as policy decisions for potential future LAIV use in Senegal and other tropical, low-resource countries in Africa.

Publication date: May 2013

Region: Africa

PATH Today (Spring 2013)

This issue of PATH Today describes PATH's multipronged approach to eliminating malaria in Africa and the development of semisynthetic artemisinin, a key ingredient in malaria treatment. It includes updates on PATH's work to prevent diarrhea in Cambodia and to diagnose cervical cancer. It also contains a profile of Dean Allen, CEO of McKinstry and PATH's board treasurer.

Publication date: May 2013

Region: Global

Part of series: PATH Today

Understanding Influenza Vaccine Performance Among Children in Senegal

This fact sheet describes a phase 2 influenza vaccine clinical study that PATH and our partners are conducting in Senegal. The study seeks to better understand the performance of seasonal influenza vaccines in a tropical, low-resource region of the country. Overall, the results from this study will provide evidence to support larger research efforts to determine the most feasible and efficient ways of protecting populations in tropical, developing Africa from influenza through the use of vaccines.

Publication date: April 2013

Region: Africa

Guide to Monitoring and Evaluation of Advocacy, Communication, and Social Mobilization to Support Tuberculosis Prevention and Care

This guide was developed to help advocacy, communication, and social mobilization (ACSM) programs at national and subnational levels strengthen routine monitoring and evaluation of tuberculosis ACSM activities. For a training curriculum that is based on the guide, see Monitoring and Evaluation of Advocacy, Communication, and Social Mobilization Interventions to Support Tuberculosis Prevention and Care: Training Curriculum.

Publication date: March 2013

Region: Global

Monitoring and Evaluation of Advocacy, Communication, and Social Mobilization Interventions to Support Tuberculosis Prevention and Care: Training Curriculum

This training curriculum was designed to build capacity for rigorous monitoring and evaluation of advocacy, communication, and social mobilization (ACSM) activities among tuberculosis prevention and care professionals, ACSM officers, and civil-society activists at national and local levels. The curriculum is based on Guide to Monitoring and Evaluation of Advocacy, Communication, and Social Mobilization to Support Tuberculosis Prevention and Care.

Publication date: March 2013

Region: Global

Barriers to Access and Use of Public TB Diagnostic Services in Vietnam

This report dissects research results assessing access to and use of public tuberculosis (TB) diagnostic services in nine districts of Vietnam. The report identifies barriers to accessing public-sector TB diagnostic services at the individual, provider, and health system levels.

Publication date: February 2013

Region: Asia

Investing in Malaria Pays Off

This infographic gives a visual representation of the cost-effectiveness of malaria interventions in Africa, showing that the malaria map is shrinking and that investing in malaria pays off.

Publication date: 2013

Region: Africa

Malaria Test for Life

This infographic gives a visual representation of PATH's three-step approach to test and treat malaria infections: rapid reporting, mass test and treat, and active surveillance.

Publication date: 2013

Region: Africa

Directions in Global Health (Volume 9, Issue 3)

This issue of Directions in Global Health highlights PATH’s work to increase access to lifesaving products for women. It features a commentary by Catharine Taylor, who directs PATH’s Maternal and Child Health and Nutrition Program. Other articles cover efforts to improve health and nutrition with orange-fleshed sweetpotatoes in Kenya, increase hepatitis B vaccination for newborns in Vietnam, fight childhood tuberculosis in Tanzania, and assess a range of technologies for their potential impact in reducing maternal deaths.

Publication date: December 2012

Region: Global

Part of series: Directions in Global Health

mHealth, eHealth, Reproductive Health (Outlook, vol. 29, no. 1)

This issue of Outlook explores the promise and current realities of new information technologies in service to reproductive health programming in low-resource settings (including HIV/AIDS prevention and treatment and maternal and child health interventions). The issue examines new approaches and looks to the future for current needs and potential solutions.

Author: Wittet S

Publication date: December 2012

Region: Global

Part of series: Outlook

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

This article, published in the New England Journal of Medicine (NEJM), reports results from a pivotal, large-scale Phase 3 trial of RTS,S/AS01 malaria vaccine. When compared to immunization with a control vaccine, infants (aged 6 to 12 weeks at first vaccination) vaccinated with RTS,S had one-third fewer episodes of both clinical and severe malaria and had similar reactions to the injection. In this trial, RTS,S demonstrated an acceptable safety and tolerability profile. The abstract of this article is available through the NEJM by clicking on "Visit web page" below, or for free access to the full lenth article please visit malariavaccine.org and click on "Read the NEJM article."

Publication date: December 2012

Region: Africa

The PATH Malaria Vaccine Initiative

The PATH Malaria Vaccine Initiative (MVI) is a vaccine development program of PATH. This fact sheet provides an overview of MVI's history, mission, vision, and work.

Publication date: November 2012

Region: Global

PATH Today (Winter 2012)

This issue of PATH Today leads with the Mama SASHA project, which is improving nutrition, agriculture, and prenatal health care in Kenya. PATH's work to increase access to breast cancer screening in rural Peru is also featured, and donors Bryan and Martha Kim share why contributing to PATH is a smart investment. News briefs include an update about family planning and new work in Myanmar.

Publication date: November 2012

Region: Global

Part of series: PATH Today

ProVIC Champion Communities: Preventing Mother-to-Child Transmission of HIV in the Democratic Republic of Congo

In the Democratic Republic of Congo (DRC), PATH and our partners are implementing the DRC Integrated HIV/AIDS Project (ProVIC), which uses a community-based approach called “champion communities” for reaching mothers to provide them with comprehensive HIV services. This case study examines the landscape of HIV in the DRC and the approach, strategies, challenges, successes, and recommendations of the ProVIC project.

Author: Saul K

Publication date: November 2012

Region: Africa

Tackling Tuberculosis and Diabetes

In low-resource settings, diabetes and tuberculosis are common among the same populations, and they amplify each other. PATH's principles and experiences guide our work in fighting these intersecting epidemics through innovation and collaboration.

Publication date: November 2012

Region: Global

Developing Drugs for Neglected Diseases: PATH Advances High-Quality, Affordable Treatments for the Developing World

This fact sheet describes PATH's drug development program, including our work to develop new treatments for malaria, kala-azar (visceral leishmaniasis), and diarrheal disease.

Publication date: September 2012

Region: Global

Part of series: Areas of focus fact sheets

MDR-TB Planning Toolkit

The MDR-TB Planning Toolkit is designed to help countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is available as a Microsoft Word file (for users who wish to modify it) and as an Adobe PDF file (recommended for printing). The worksheets can be filled out on the screen using the full toolkit or the worksheets-only version. The Excel version of Tool 2 has built-in formulas that also generate graphs to show a country’s baseline performance and targets for MDR-TB case detection, enrollment, and successful treatment. (The 2009 MDR/XDR-TB Assessment and Monitoring Tool can be found here.)

Author: Royce S, Islam T, Jakubowiak W, Garcia Baena I, Mueller L, Reed L, Richardson D

Publication date: September 2012

Region: Global

Public-Private Mix for TB-HIV Control

This fact sheet provides an overview of PATH's work in Vietnam to control tuberculosis and HIV by enhancing referrals from the private sector to existing public-sector prevention and treatment services, thus improving case detection.

Publication date: September 2012

Region: Asia

Reducing the Burden of Disease: PATH Provides Tools and Expertise to Address Global Health Threats

This fact sheet summarizes PATH's work to curb emerging and epidemic diseases such as HIV/AIDS, tuberculosis, and malaria. Topic areas include advancing technologies to improve prevention, diagnosis, and treatment; strengthening health systems; encouraging healthy behaviors; and mobilizing and supporting our partners.

Publication date: September 2012

Region: Global

Part of series: Areas of focus fact sheets

Page 5 of 18